Literature DB >> 7870995

Chronic treatments with cholinoceptor drugs influence spatial learning in rats.

F A Abdulla1, M R Calaminici, J D Stephenson, J D Sinden.   

Abstract

Nicotine, scopolamine, oxotremorine, diisopropyl-fluorophosphate (DFP) and tetrahydroaminoacridine (THA) were administered chronically to different groups of rats in doses reported to alter central muscarinic and/or nicotinic receptor numbers. Beginning 24 h after final drug injection, the groups were compared to a vehicle control group on acquisition of a hidden platform position in the Morris water maze over 20 trials with a 30-min inter-trial interval. Chronic treatment with either nicotine or scopolamine significantly improved the rate of learning, but oxotremorine and DFP retarded learning and THA had no effect on learning. The chronic drug effects on behaviour were consistent with known effects of the injected drugs on muscarinic and nicotinic binding in the forebrain and on the sensitivity of frontal cortex neurones to iontophoretically applied cholinoceptor agonists. However, alternative explanations for the observed changes cannot be ruled out, since the drugs used are known to have a wide range of effects on other neurotransmitters.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7870995     DOI: 10.1007/bf02253544

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  25 in total

1.  Effect of chronic nicotine treatment on nicotinic autoreceptor function and N-[3H]methylcarbamylcholine binding sites in the rat brain.

Authors:  P A Lapchak; D M Araujo; R Quirion; B Collier
Journal:  J Neurochem       Date:  1989-02       Impact factor: 5.372

2.  Effects of oral physostigmine in Alzheimer's disease.

Authors:  Y Stern; M Sano; R Mayeux
Journal:  Ann Neurol       Date:  1987-09       Impact factor: 10.422

3.  [Studies on the metabolism of tropane alkaloids. 8. Chemical analysis of (-)-scopolamine metabolism in several mammals].

Authors:  G Werner; K H Schmidt
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1968-06

4.  Effect of acute administration of nicotine on in vivo release of noradrenaline in the hippocampus of freely moving rats: a dose-response and antagonist study.

Authors:  M P Brazell; S N Mitchell; J A Gray
Journal:  Neuropharmacology       Date:  1991-08       Impact factor: 5.250

5.  Tacrine in Alzheimer's disease.

Authors:  S A Eagger; R Levy; B J Sahakian
Journal:  Lancet       Date:  1991-04-27       Impact factor: 79.321

6.  Nicotinic systems and cognitive function.

Authors:  E D Levin
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

7.  Tetrahydroaminoacridine induces opposite changes in muscarinic and nicotinic receptors in rat brain.

Authors:  L Nilsson-Håkansson; Z Lai; A Nordberg
Journal:  Eur J Pharmacol       Date:  1990-09-21       Impact factor: 4.432

8.  Preferential stimulation of ventral tegmental area dopaminergic neurons by nicotine.

Authors:  G Mereu; K W Yoon; V Boi; G L Gessa; L Naes; T C Westfall
Journal:  Eur J Pharmacol       Date:  1987-09-23       Impact factor: 4.432

9.  Patterns of memory failure after scopolamine treatment: implications for cholinergic hypotheses of dementia.

Authors:  W W Beatty; N Butters; D S Janowsky
Journal:  Behav Neural Biol       Date:  1986-03

10.  Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type.

Authors:  W K Summers; L V Majovski; G M Marsh; K Tachiki; A Kling
Journal:  N Engl J Med       Date:  1986-11-13       Impact factor: 91.245

View more
  5 in total

1.  Increased neurodegeneration during ageing in mice lacking high-affinity nicotine receptors.

Authors:  M Zoli; M R Picciotto; R Ferrari; D Cocchi; J P Changeux
Journal:  EMBO J       Date:  1999-03-01       Impact factor: 11.598

Review 2.  Nicotinic receptors, amyloid-beta, and synaptic failure in Alzheimer's disease.

Authors:  Sofia Jürgensen; Sergio T Ferreira
Journal:  J Mol Neurosci       Date:  2009-08-19       Impact factor: 3.444

3.  Relationship between up-regulation of nicotine binding sites in rat brain and delayed cognitive enhancement observed after chronic or acute nicotinic receptor stimulation.

Authors:  F A Abdulla; E Bradbury; M R Calaminici; P M Lippiello; S Wonnacott; J A Gray; J D Sinden
Journal:  Psychopharmacology (Berl)       Date:  1996-04       Impact factor: 4.530

Review 4.  Tacrine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in Alzheimer's disease.

Authors:  A J Wagstaff; D McTavish
Journal:  Drugs Aging       Date:  1994-06       Impact factor: 3.923

5.  Poly(lactic-co-glycolic Acid) Nanoparticle Encapsulated 17β-Estradiol Improves Spatial Memory and Increases Uterine Stimulation in Middle-Aged Ovariectomized Rats.

Authors:  Alesia V Prakapenka; Alicia M Quihuis; Catherine G Carson; Shruti Patel; Heather A Bimonte-Nelson; Rachael W Sirianni
Journal:  Front Behav Neurosci       Date:  2020-12-16       Impact factor: 3.558

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.